Chimin Health Management Co., Ltd. (SHA:603222)

Market Cap	5.39B
Revenue (ttm)	676.53M
Net Income (ttm)	-137.85M
Shares Out	523.09M
EPS (ttm)	-0.25
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	15,669,808
Average Volume	55,898,482
Open	10.22
Previous Close	10.31
Day's Range	10.20 - 10.54
52-Week Range	5.22 - 15.10
Beta	0.13
RSI	44.00
Earnings Date	Oct 28, 2025

About Chimin Health Management

Chimin Health Management Co., Ltd., together with its subsidiaries, researches, develops, produces, and sells human medicines and medical devices in China and internationally. The company provides non-PVC double-tube double-valve, single-tube single-valve, and single-tube double-valve soft bags; plastic bottles; and other packaging forms. It also offers medical instruments, including safety syringes, safety injection needles, sterile syringes, irrigators, dispensers, insulin syringes, infusion sets, precision filter infusion sets, and other pro...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1996
• Employees: 1,994
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 603222

Financial Performance

In 2024, Chimin Health Management's revenue was 775.73 million, a decrease of -13.28% compared to the previous year's 894.51 million. Losses were -59.71 million, -8.81% less than in 2023.